CSL share price lower despite UK Government deal

CSL has got the UK's back if there's another pandemic.

| More on:
A smiling young woman sits on a bridge in London checking her online shopping, indicating share price movement for ASX BNPL shares overseas.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price is falling on Wednesday.

In morning trade, the biotherapeutics giant's shares are down 1.5% to $251.94.

Why is the CSL share price falling?

Investors have been selling the company's shares today after broad market weakness offset the release of some potentially positive news.

At the time of writing, the ASX 200 index is down 0.25% following a very poor night of trade on Wall Street.

What did CSL announce?

Overnight, CSL announced a deal between its CSL Seqirus business and the UK government.

According to the release, CSL Seqirus will develop and supply pandemic influenza vaccines in the event of an influenza pandemic.

Under the terms of the agreement, should an influenza pandemic be declared, the UK government would have the option to purchase more than 100 million doses of pandemic vaccines from the CSL Seqirus manufacturing plant in Liverpool in a rapid timeframe.

CSL Seqirus' global executive director for pandemic, Marc Lacey, commented:

CSL Seqirus is a global leader in pandemic influenza preparedness, and we're pleased the UK government will continue to partner with us in preparing to provide protection against the potential of a flu pandemic. This agreement will help to ensure the UK maintains robust preparedness and rapid response capabilities for this potential future threat.

Lorna Meldrum from CSL Seqirus added:

CSL Seqirus has been an active and reliable partner to the UK across pandemic influenza vaccines for many years. We are proud to play a continued part in ensuring ever higher levels of influenza preparedness in the UK and globally.

No financial terms were disclosed for the deal.

While this is good news for the company, let's hope that CSL Seqirus won't be needed!

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Guess which ASX 200 stock just jumped 9% on big news

Let's find out what is getting investors excited today.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

What are Cochlear shares worth according to Macquarie?

Let's see what the broker is saying about this blue chip.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

When will CSL shares finally catch a break?

Here's where analysts think the biotech stock is heading next.

Read more »

An analyst wearing a dark blue shirt and glasses sits at his computer with his chin resting on his hands as he looks at the CBA share price movement today
Healthcare Shares

JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?

Can this ASX 200 juggernaut go higher?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why this top broker expects CSL shares to surge 26%

A leading broker foresees a big rebound ahead for CSL shares. But why?

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

Guess which ASX All Ords stock is jumping on big US news

This small cap is catching the eye on Thursday. But why?

Read more »